Ginkgo Bioworks Holdings, Inc. (DNA)

USD 7.71

(2.25%)

Total Debt Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual total debt in 2023 was 241.76 Million USD , down -45.37% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly total debt in 2024 Q2 was 452.26 Million USD , up 92.87% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported annual total debt of 442.58 Million USD in 2022, up 1821.79% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported annual total debt of 23.03 Million USD in 2021, up 35.45% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly total debt of 234.49 Million USD for 2024 Q1, down -3.01% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly total debt of 241.76 Million USD for 2023 FY, down -45.37% from previous quarter.

Annual Total Debt Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Total Debt of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Total Debt Total Debt Growth
2023 241.76 Million USD -45.37%
2022 442.58 Million USD 1821.79%
2021 23.03 Million USD 35.45%
2020 17 Million USD 1.41%
2019 16.76 Million USD 0.0%
2001 413.25 Million USD 0.0%

Peer Total Debt Comparison of Ginkgo Bioworks Holdings, Inc.

Name Total Debt Total Debt Difference
ADC Therapeutics SA 124.37 Million USD -94.383%
Alto Neuroscience, Inc. 151.46 Million USD -59.622%
Annovis Bio, Inc. - USD -Infinity%
Biohaven Pharmaceutical Holding Company Ltd. 30.87 Million USD -683.004%
Nuvation Bio Inc. 4 Million USD -5933.643%
Nuvation Bio Inc. 4 Million USD -5933.643%
Arcus Biosciences, Inc. 11 Million USD -2097.891%
Zymeworks Inc. 26.72 Million USD -804.753%